113 related articles for article (PubMed ID: 494575)
1. Preparation of stable intermediate-purity factor VIII concentrate with a note on high-purity factor VIII.
Margolis J; Rhoades P
Vox Sang; 1979; 36(6):369-74. PubMed ID: 494575
[TBL] [Abstract][Full Text] [Related]
2. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
Vermeer C; Soute BA; Ates G; Brummelhuis HG
Vox Sang; 1976; 30(1):1-22. PubMed ID: 1251567
[TBL] [Abstract][Full Text] [Related]
3. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
[TBL] [Abstract][Full Text] [Related]
4. Modified glycine precipitation technique for the preparation of factor VIII concentrate of high purity and high stability.
Brodniewicz-Proba T; Beauregard D
Vox Sang; 1987; 52(1-2):10-4. PubMed ID: 3111087
[TBL] [Abstract][Full Text] [Related]
5. A process for preparation of 'high-purity' factor VIII by controlled pore glass treatment.
Margolis J; Gallovich CM; Rhoades P
Vox Sang; 1984; 46(6):341-8. PubMed ID: 6431689
[TBL] [Abstract][Full Text] [Related]
6. A heat-treated factor VIII concentrate prepared by controlled-pore glass adsorption chromatography.
Benny AG; Scott RH; Woodfield DG
Transfusion; 1987; 27(2):174-7. PubMed ID: 3103269
[TBL] [Abstract][Full Text] [Related]
7. Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield.
Wensley RT; Snape TJ
Vox Sang; 1980; 38(4):222-8. PubMed ID: 6774480
[TBL] [Abstract][Full Text] [Related]
8. Cryoprecipitate of intermediate purity produced in a closed thaw-siphon system from DDAVP stimulated blood donor plasma.
Konecka G; Bykowska K; Ludwicka A; Letowska M; Wegrzynowicz Z; Sablinski J; Lopaciuk S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):565-70. PubMed ID: 1714861
[TBL] [Abstract][Full Text] [Related]
9. Controlled pore glass factor VIII concentrate: influence of heat treatment.
Ockelford PA; Benny AG; Berry EW; Johns AS; Woodfield DG
Pathology; 1987 Jan; 19(1):56-7. PubMed ID: 3108838
[TBL] [Abstract][Full Text] [Related]
10. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
Mason EC; Pepper DS; Griffin B
Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
[TBL] [Abstract][Full Text] [Related]
11. Severely heated therapeutic factor VIII concentrate of high specific activity.
Winkelman L; Owen NE; Evans DR; Evans H; Haddon ME; Smith JK; Prince PJ; Williams JD; Lane RS
Vox Sang; 1989; 57(2):97-103. PubMed ID: 2506696
[TBL] [Abstract][Full Text] [Related]
12. Preparation of intermediate-purity factor VIII concentrate by direct gel filtration of cryoprecipitate.
Teh LC
Vox Sang; 1993; 65(4):251-7. PubMed ID: 8310677
[TBL] [Abstract][Full Text] [Related]
13. Improved yields of factor VIII from heparinized plasma.
Rock GA; Cruickshank WH; Tackaberry ES; Palmer DS
Vox Sang; 1979; 36(5):294-300. PubMed ID: 462918
[TBL] [Abstract][Full Text] [Related]
14. A factor VIII concentrate of intermediate purity and higher potency.
Smith JK; Evans DR; Stone V; Snape TJ
Transfusion; 1979; 19(3):299-306. PubMed ID: 36691
[TBL] [Abstract][Full Text] [Related]
15. [Factor VIII concentrate, highly purified and heated in solution (author's transl)].
Heimburger N; Schwinn H; Gratz P; Lüben G; Kumpe G; Herchenhan B
Arzneimittelforschung; 1981; 31(4):619-22. PubMed ID: 6788045
[TBL] [Abstract][Full Text] [Related]
16. Preparation of cryoprecipitated factor VIII concentrates.
Slichter SJ; Counts RB; Henderson R; Harker LA
Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
[TBL] [Abstract][Full Text] [Related]
17. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
[TBL] [Abstract][Full Text] [Related]
18. Preparation of factor VIII concentrates by cryoprecipitate sedimentation.
Boudart DJ; Naud MF
Transfusion; 1979; 19(5):594-6. PubMed ID: 505533
[TBL] [Abstract][Full Text] [Related]
19. [Development and characterization of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
Ristol P; Gensana M; Fernández J; Massot M; Bhattacharya P; Jorquera JI
Sangre (Barc); 1996 Apr; 41(2):125-30. PubMed ID: 9045352
[TBL] [Abstract][Full Text] [Related]
20. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
